AGEN vs CLOV · P/E 1.6, rev $103.5M vs rev $1.37B
Agenus Inc (AGEN) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Agenus Inc (AGEN) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported AGEN revenue for 2024-12-31 was $103.5M. Net income was -$232.3M. Revenue was down 33.8% from 2023-12-31 to 2024-12-31. AGEN currently screens at market cap $134.5M and trailing P/E 1.6.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
AGEN currently screens at market cap $134.5M and trailing P/E 1.6. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the AGEN and CLOV stock pages for the full models.
Not investment advice.